Roth Conference Archives - Page 90 of 117

TuesdayMar 14, 2017 5:00 pm

Jaguar Animal Health, Inc. (NASDAQ: JAGX) Starts Presentation at 29th Annual ROTH Conference

Jaguar Animal Health (NASDAQ: JAGX) is an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value horses. Canalevia™ is Jaguar’s lead prescription drug product candidate, intended for the treatment of various forms of diarrhea in dogs. Equilevia™ is Jaguar’s prescription drug product candidate for the treatment of gastrointestinal ulcers in horses. Canalevia™ and Equilevia™ contain ingredients isolated and purified from the Croton lechleri tree, which is sustainably harvested. Neonorm™ Calf and Neonorm™ Foal are the company’s lead non-prescription products. Neonorm™ is a standardized botanical extract derived from the Croton lechleri tree. Jaguar has nine active investigational new animal drug applications,…

TuesdayMar 14, 2017 5:00 pm

Oclaro, Inc. (NASDAQ: OCLR) Starts Presentation at 29th Annual Roth Conference

Oclaro (NASDAQ: OCLR) designs, manufactures and markets lasers and optical components, modules and subsystems for the optical communications, industrial, and consumer laser markets worldwide. The company’s products generate, detect, combine and separate light signals in optical communications networks. It offers client side transceivers, including pluggable transceivers; line side transceivers; tunable laser transmitters such as discrete lasers and co-packaged laser modulators; lithium niobate modulators to manipulate the phase or the amplitude of an optical signal; transponder modules for transmitter and receiver functions; and discrete lasers and receivers for metro and long-haul applications. For more information, visit the company’s website at www.oclaro.com.…

TuesdayMar 14, 2017 5:00 pm

Novelion Therapeutics, Inc. (NASDAQ: NVLN) Starts Presentation at 29th Annual Roth Conference

Novelion Therapeutics (NASDAQ: NVLN) is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development. Novelion has a diversified commercial portfolio through its indirect subsidiary, Aegerion Pharmaceuticals, Inc., which includes MYALEPT® and JUXTAPID®, and is also developing zuretinol acetate for the potential treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes. For more information, visit the company’s website at www.novelion.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press…

TuesdayMar 14, 2017 5:00 pm

ATN International, Inc. (NASDAQ: ATNI) Starts Presentation at 29th Annual ROTH Conference

ATN International (NASDAQ: ATNI), headquartered in Beverly, Massachusetts, provides telecommunications services to rural, niche and other under-served markets and geographies in the United States, Bermuda and the Caribbean and owns and operates solar power systems in select locations in the United States and India. Through its operating subsidiaries, the company provides both wireless and wireline connectivity to residential and business customers, including a range of mobile wireless solutions, local exchange services and broadband internet services as well as distributed solar electric power to corporate, utility and municipal customers. Additionally, ATN is the owner and operator of terrestrial and submarine fiber optic transport systems. For more information, visit the…

TuesdayMar 14, 2017 4:30 pm

H2O Innovation, Inc. (HEOFF) Starts Presentation at 29th Annual ROTH Conference

H2O Innovation (OTC: HEOFF) designs and provides custom-built, integrated water treatment solutions based on membrane filtration technology for municipal, industrial, energy and natural resources end-users. The company’s activities rely on three pillars which are i) water and wastewater projects; ii) specialty products and services, including a complete line of specialty chemicals, consumables, specialized products for the water treatment industry as well as control and monitoring systems; and iii) operation and maintenance services for water and wastewater treatment systems. For more information, visit the company’s website at www.h2oinnovation.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services…

TuesdayMar 14, 2017 4:30 pm

MaxLinear, Inc. (NYSE: MXL) Starts Presentation at 29th Annual Roth Conference

MaxLinear (NYSE: MXL) provides radio-frequency (RF) and mixed-signal circuits for broadband communications, data center, metro, and long-haul transport network applications worldwide. The company offers RF receivers and RF receiver systems-on-chips to receive and demodulate broadband signals, modem solutions, and physical medium devices that provide a constant current source, current-to-voltage regulation, and data alignment and retiming functionality in optical interconnect applications. Its products are integrated into a range of electronic devices, including cable and terrestrial and satellite set-top boxes and gates, DOCSIS data and voice gateways, hybrid analog and digital televisions, satellite low-noise blocker transponders or outdoor units, and physical medium…

TuesdayMar 14, 2017 4:30 pm

Cryoport, Inc. (NASDAQ: CYRX) Starts Presentation at 29th Annual ROTH Conference

Cryoport (NASDAQ: CYRX) is a global provider of cold chain logistics solutions for temperature-sensitive life sciences commodities. The company serves the biopharmaceutical market with logistics solutions for biologic materials, such as regenerative medicine, including immunotherapies, stem cells and CAR-T cells. The company's solutions are used by points-of-care, CRO's, central laboratories, pharmaceutical companies, manufacturers, and university researchers. The company also serves the reproductive medicine market, primarily in IVF and surrogacy; and the animal health market, primarily in the areas of vaccines and reproduction. Cryoport's proprietary Cryoport Express® Shippers, Cryoportal™ Logistics Management Platform, SmartPak II™ Condition Monitoring System and geo-sensing technology, paired…

TuesdayMar 14, 2017 4:30 pm

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Starts Presentation at 29th Annual ROTH Conference

Aerie Pharmaceuticals (NASDAQ: AERI) is a clinical stage pharmaceutical company focusing on the discovery of innovative treatments for glaucoma and other eye ailments. Its leading product candidates, Rhopressa™ and Roclatan™, are believed to be effective for most glaucoma patients, based on clinical trials results, and are currently in different stages of development in view of commercialization. Aerie is also focused on the development of additional product candidates and technologies in ophthalmology. For more information, visit the company’s website at www.aeriepharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication…

TuesdayMar 14, 2017 4:30 pm

Aegion Corp. (NASDAQ: AEGN) Starts Presentation at 29th Annual ROTH Conference

Aegion (NASDAQ: AEGN) maintains, rehabilitates and strengthens infrastructure around the world. Since 1971, the company has played a pioneering role in finding transformational solutions to rehabilitate aging infrastructure, primarily pipelines in the wastewater, water, energy, mining and refining industries. Aegion also maintains the efficient operation of refineries and other industrial facilities and provides innovative solutions for the strengthening of buildings, bridges and other structures. For more information, visit the company’s website at www.aegion.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution…

TuesdayMar 14, 2017 4:30 pm

Glu Mobile, Inc. (NASDAQ: GLUU) Starts Presentation at 29th Annual ROTH Conference

Glu Mobile (NASDAQ:GLUU) is a global developer and publisher of free-to-play mobile games. The company is focused on creating compelling original IP games such as Contract Killer, Cooking Dash, Covet Fashion, Deer Hunter, Design Home, Quizup, Racing Rivals, and Tap Sports Baseball, and branded IP games including Gordon Ramsay Dash, Kendall & Kylie, and Kim Kardashian: Hollywood on the App Store, Google Play and Amazon Appstore. Founded in 2001, Glu is headquartered in San Francisco with U.S. offices outside Seattle and in Burlingame, San Mateo, Long Beach and Portland, and international locations in Canada, China, India, Japan, and Russia. For…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Category: Roth Conference

Jaguar Animal Health, Inc. (NASDAQ: JAGX) Starts Presentation at 29th Annual ROTH Conference

Oclaro, Inc. (NASDAQ: OCLR) Starts Presentation at 29th Annual Roth Conference

Novelion Therapeutics, Inc. (NASDAQ: NVLN) Starts Presentation at 29th Annual Roth Conference

ATN International, Inc. (NASDAQ: ATNI) Starts Presentation at 29th Annual ROTH Conference

H2O Innovation, Inc. (HEOFF) Starts Presentation at 29th Annual ROTH Conference

MaxLinear, Inc. (NYSE: MXL) Starts Presentation at 29th Annual Roth Conference

Cryoport, Inc. (NASDAQ: CYRX) Starts Presentation at 29th Annual ROTH Conference

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Starts Presentation at 29th Annual ROTH Conference

Aegion Corp. (NASDAQ: AEGN) Starts Presentation at 29th Annual ROTH Conference

Glu Mobile, Inc. (NASDAQ: GLUU) Starts Presentation at 29th Annual ROTH Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search